The role of apoptosis in preeclampsia

Israel Medical Association Journal

Volumn 7, Issue 3, 2005, Pages 178-181

  Levy, Roni ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Apoptosis; Hypoxia; p53; Placenta; Preeclampsia

Indexed keywords

DNA; FAS ANTIGEN; FAS LIGAND; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HLA G ANTIGEN; MATRIX METALLOPROTEINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 1;

ANTIGEN BINDING; ANTIGEN EXPRESSION; APOPTOSIS; CELL ACTIVITY; CELL PROTECTION; CELL TRANSPORT; DNA DAMAGE; DNA REPAIR; DOPPLER ECHOGRAPHY; ENDOTHELIUM INJURY; EXPERIMENTAL MODEL; FETOPLACENTAL UNIT; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOXIA; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MOTHER; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PROTEIN EXPRESSION; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; SYNCYTIOTROPHOBLAST; T LYMPHOCYTE; TROPHOBLAST; UTERINE ARTERY;

APOPTOSIS; CELL HYPOXIA; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY;

EID: 15844401953     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359-75.
2. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001;184(96):1249-50.
3. Harirah H, Donia SE, Hsu CD. Serum soluble Fas in the syndrome of hemolysis, elevated liver enzymes, low platelets. Obstet Gynecol 2001;98(2):295-8.
4. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol 2000;96:271-6.
5. Hsu CD, Harirah H, Basherra H, Mor G. Serum soluble Fas levels in preeclampsia. Obstet Gynecol 2001;97(4):530-2.
6. Ishihara N, Matsuo H. Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002;186(1):158-66.
7. Darmochwal-Kolarz D, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. Fas antigen expression on the decidual lymphocytes of pre-eclamptic patients. Am J Reprod Immunol 2000;43(4):197-201.
8. Kerr JFR, Wylie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
9. Green DR. Apoptotic pathways: the roads to ruin. Cell 1998;94:695-8.
10. Levy R, Smith DS, Chandler K, Sadovsky Y, Nelson DM. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol 2000;278:C982-8.
11. Banasiak KJ, Haddad GG. Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res 1998;797:295-304.
12. Long X, Boluyt A, Hipolito B, et al. P53 and the hypoxia-induced apoptosis of cultured neonatal rat cardiac myocytes. J Clin Invest 1997;99:2635-43.
13. Bulmar J, Johnson P. Immunohistological characterization of the decidual leukocytes infiltrate related to endometrial gland epithelium in early human pregnancy. Immunology 1985;55:35-44.
14. Le Bouteiller P, Pizzato N, Barakonyi A, Solier C. HLA-G, preeclampsia, immunity and vascular events. J Reprod Immunol 2003;59:219-34.
15. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
16. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270(5239):1189-92.
17. Pearson H. Reproductive immunology: immunity's pregnant pause. Nature 2002;420(6913):265-6.
18. Runic R, Lockwood CJ, Ma Y, Dipasquala B, Guller S. Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal surviving. J Clin Endocrinol Metab 1996;81:3119-22.
19. Uckan D, Steele A, Wang B-Y, et al. Throphoblasts express Fas ligand: a proposed mechanism of immune privilege in placenta and maternal invasion. Mol Hum Reprod 1997;3:655-62.
20. Hammer A, Blaschitz A, Daxbock C, Walcher W, Dohr G. Fas and Fas-ligand are expressed in the uteroplacental unit of first trimester pregnancy. Am J Reprod Immunol 1999;41:41-51.
21. Hunt JS, Vassmer D, Ferguson TA, Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997;158:4122-8.
22. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994;15:819-35.
23. Reister F, Frank H-G, Kingdom JCP, et al. Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001;81:1143-52.
24. Wang Y, Walsh SW. TNF-α concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996;32:157-69.
25. Fisher SJ, Roberts JM. Defects in placentation and placental perfusion. In: Linheimer MD, Roberts JM, Cunningham FG, Chesley WS, eds. Hypertensive Disorders in Pregnancy. 2nd edn. Stanford, CT: Appleton & Lange, 1999:377-94.
26. Nelson DM, Johnson RD, Smith SD, Anteby EY, Sadovsky Y. Hypoxia limits differentiation and upregulates expression and activity of PGH synthase 2 in culture trophoblast from term human placenta. Am J Obstet Gynecol 1999;180:896-902.
27. DiFederico E, Genbacev O, Fisher SJ. Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 1999;155(1):293-7.
28. Leach RE, Romero R, Kim YM, et al. Preeclampsia and expression of heparin-binding EGF like growth factor. Lancet 2002;1936(9341):1215-19.
29. Levy R, Smith DS, Sadovsky Y, Nelson DM. Apoptosis and p53 are enhanced in placentas from pregnancies complicated by fetal growth restriction induced by hypoxia. Am J Obstet Gynecol 2002;186(5):1056-61.
30. Stempian-Oteero A, Karsan A, Cornejo CJ, et al. Mechanism of hypoxia-induced endothelial cell death. J Cell Biol 1999;274:8039-45.
31. Crocker IP, Cooper S, Ong SC, Baker PN. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblast in normal pregnancy to those complicated by preeclampsia and intrauterine growth restriction. Am J Pathol 2003;162(2):637-43.
32. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991;4:700-8.
33. Kamran Y, Smith DS, Levy R, Schaiff WT, Sadovsky Y, Nelson DM. Thromboxane A2 limits differentiation and enhances apoptosis of cultured human trophoblast. Pediatr Res 2001;50(2):203-9.
34. Redman CW, Sargent IL. Placental debris, oxidative stress and preeclampsia. Placenta 2000;21(7):597-602.
35. Nelson DM. Apoptotic changes occur in the syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996;17:387-91.
36. Huppertz B, Frank HG, Kingdom JCP, Reister F, Kaufman P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998;110:495-508.
37. Mayhew TM, Leach L, McGee R, Ismail WW, Myklebust R, Lammiman MJ. Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation. Placenta 1999;20:407-2.
38. Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonat Med 2003; 13(1):39-44.
39. Hung TH, Charnock-Jones DS, Skepper JN, Burton GI. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxiareoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004;164(3):1049-61.
40. Levine RJ, Qian C, Leshane ES, et al. Two stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004;190 (3):707-13.